Nauru vs New Caledonia: The number of people with susceptibility test result for rifampicin
Nauru
14
in 2021
New Caledonia
15
in 2021
Nauru rank
136th
New Caledonia rank
135th
The number of people with susceptibility test result for rifampicin over time
- Nauru
- New Caledonia
How they compare
New Caledonia currently reports 15 against 14 in Nauru, a difference of 1.
That makes New Caledonia's figure about 1.1 times Nauru's.
Across all 5 years both countries report, New Caledonia has been ahead every year.
Nauru ranks 136th and New Caledonia ranks 135th of 155 countries.
New Caledonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Nauru | New Caledonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0 | 21.33 | 21.33 | New Caledonia |
| 2020s | 7 | 19.5 | 12.5 | New Caledonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Nauru or New Caledonia?
- New Caledonia, at 15 against 14 in Nauru as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Nauru and New Caledonia?
- 1, with New Caledonia ahead.
- How many years of comparable data are there for Nauru and New Caledonia?
- 5 years are reported by both, from 2017 to 2021.
- How do Nauru and New Caledonia rank globally for the number of people with susceptibility test result for rifampicin?
- Nauru ranks 136th and New Caledonia ranks 135th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.